SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc. has received a Health Canada medical device licence for Canada's first and only objective, rapid neuro-physiological brain function assessment system ...

BOSTON, April 9, 2024 /PRNewswire/ -- NeuroCatch Inc., a leading medical device company that enables rapid access to an objective assessment of brain health at the point of care, today announced the ...

- Enhanced Brain Function Assessment System Objectively Evaluates Cognitive Brain Function in Minutes at the Point of Care - BOSTON, MA / ACCESSWIRE / August 2, 2022 / NeuroCatch Inc. ("NCI"), a ...

NeuroCatch Inc., a brain-focused health technology company committed to translating research innovations into real-world medical devices and applications, is pleased to announce a research ...

The NeuroCatch Platform is a 6-Minute Brain Function Assessment System Licensed by Health Canada as a Class II Medical Device VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) -- KetamineOne ...

Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada SURREY, BC, March 28, 2019 /CNW/ - NeuroCatch Inc.

Objective brain function assessment system revolutionizes the ABCs of cognitive function Soon to be available to clinicians and researchers in Canada A wholly owned subsidiary of HealthTech Connex, ...